Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |